New article in Forbes online covering a recent review of the evidence for anticancer activity of cannabinoids: https://bit.ly/47XYSEG. #Cancer "The review also illustrates the need for continued research into cannabinoids and cancer, including controlled randomized trials to develop standardized therapeutic protocols. In existing research, “significant differences in effects are observed based on concentration, cannabinoid type, and cancer type,” Caplan notes. “For example, THC can have both inhibitory and stimulatory effects on breast cancer cell proliferation depending on receptor activation pathways.” “Cannabinoids interact with multiple pathways, sometimes leading to unintended pro-tumor effects,” he writes. “The review suggests caution, as these mechanisms are not fully understood and require further exploration. Indeed, the endocannabinoid system may be one of the pivotal ‘drivers’ of physiology, but we have yet to determine which elements stimulate or inhibit its effects.” PDF of the review paper described: https://bit.ly/48g7qal

Posted by Coral Henshaw at 2024-10-18 00:35:29 UTC